Literature DB >> 25728675

TRIM25 has a dual function in the p53/Mdm2 circuit.

P Zhang1,2, S Elabd1, S Hammer3, V Solozobova1, H Yan1,2, F Bartel3, S Inoue4, T Henrich5, J Wittbrodt6, F Loosli1, G Davidson1, C Blattner1.   

Abstract

P53 is an important tumor suppressor that, upon activation, induces growth arrest and cell death. Control of p53 is thus of prime importance for proliferating cells, but also for cancer therapy, where p53 activity contributes to the eradication of tumors. Mdm2 functionally inhibits p53 and targets the tumor suppressor protein for degradation. In a genetic screen, we identified TRIM25 as a novel regulator of p53 and Mdm2. TRIM25 increased p53 and Mdm2 abundance by inhibiting their ubiquitination and degradation in 26 S proteasomes. TRIM25 co-precipitated with p53 and Mdm2 and interfered with the association of p300 and Mdm2, a critical step for p53 polyubiquitination. Despite the increase in p53 levels, p53 activity was inhibited in the presence of TRIM25. Downregulation of TRIM25 resulted in an increased acetylation of p53 and p53-dependent cell death in HCT116 cells. Upon genotoxic insults, TRIM25 dampened the p53-dependent DNA damage response. The downregulation of TRIM25 furthermore resulted in massive apoptosis during early embryogenesis of medaka, which was rescued by the concomitant downregulation of p53, demonstrating the functional relevance of the regulation of p53 by TRIM25 in an organismal context.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25728675     DOI: 10.1038/onc.2015.21

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  28 in total

1.  MDM2 inhibits p300-mediated p53 acetylation and activation by forming a ternary complex with the two proteins.

Authors:  E Kobet; X Zeng; Y Zhu; D Keller; H Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

2.  Mdm2 facilitates the association of p53 with the proteasome.

Authors:  Roman Kulikov; Justine Letienne; Manjit Kaur; Steven R Grossman; Janine Arts; Christine Blattner
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-17       Impact factor: 11.205

3.  Cancer. p53, guardian of the genome.

Authors:  D P Lane
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

Review 4.  Regulation of p53--insights into a complex process.

Authors:  Karen A Boehme; Christine Blattner
Journal:  Crit Rev Biochem Mol Biol       Date:  2009 Nov-Dec       Impact factor: 8.250

5.  Increasing 14-3-3 sigma expression with declining estrogen receptor alpha and estrogen-responsive finger protein expression defines malignant progression of endometrial carcinoma.

Authors:  Hiroko Nakayama; Takaaki Sano; Atsushi Motegi; Tetsunari Oyama; Takashi Nakajima
Journal:  Pathol Int       Date:  2005-11       Impact factor: 2.534

6.  Estrogen-dependent and independent activation of the P1 promoter of the p53 gene in transiently transfected breast cancer cells.

Authors:  C Hurd; S Dinda; N Khattree; V K Moudgil
Journal:  Oncogene       Date:  1999-01-28       Impact factor: 9.867

7.  USP10 regulates p53 localization and stability by deubiquitinating p53.

Authors:  Jian Yuan; Kuntian Luo; Lizhi Zhang; John C Cheville; Zhenkun Lou
Journal:  Cell       Date:  2010-01-21       Impact factor: 41.582

8.  Efp targets 14-3-3 sigma for proteolysis and promotes breast tumour growth.

Authors:  Tomohiko Urano; Tomoyuki Saito; Tohru Tsukui; Masayo Fujita; Takayuki Hosoi; Masami Muramatsu; Yasuyoshi Ouchi; Satoshi Inoue
Journal:  Nature       Date:  2002-06-20       Impact factor: 49.962

9.  Both germ line and somatic genetics of the p53 pathway affect ovarian cancer incidence and survival.

Authors:  Frank Bartel; Juliane Jung; Anja Böhnke; Elise Gradhand; Katharina Zeng; Christoph Thomssen; Steffen Hauptmann
Journal:  Clin Cancer Res       Date:  2008-01-01       Impact factor: 12.531

Review 10.  TRIM family proteins: retroviral restriction and antiviral defence.

Authors:  Sébastien Nisole; Jonathan P Stoye; Ali Saïb
Journal:  Nat Rev Microbiol       Date:  2005-10       Impact factor: 60.633

View more
  35 in total

Review 1.  Precision autophagy directed by receptor regulators - emerging examples within the TRIM family.

Authors:  Tomonori Kimura; Michael Mandell; Vojo Deretic
Journal:  J Cell Sci       Date:  2016-02-15       Impact factor: 5.285

Review 2.  TRIMming p53's anticancer activity.

Authors:  S Elabd; G Meroni; C Blattner
Journal:  Oncogene       Date:  2016-02-22       Impact factor: 9.867

3.  DeSUMOylation switches Kaiso from activator to repressor upon hyperosmotic stress.

Authors:  Svetlana Zhenilo; Igor Deyev; Ekaterina Litvinova; Nadezhda Zhigalova; Daria Kaplun; Alexey Sokolov; Alexander Mazur; Egor Prokhortchouk
Journal:  Cell Death Differ       Date:  2018-02-22       Impact factor: 15.828

4.  Fam83F induces p53 stabilisation and promotes its activity.

Authors:  Mohammed Salama; Diego Benitez-Riquelme; Seham Elabd; Leonel Munoz; Ping Zhang; Matthias Glanemann; Maria Caterina Mione; Robert Goldin; Thierry Soussi; Gary Davidson; Christine Blattner
Journal:  Cell Death Differ       Date:  2019-01-28       Impact factor: 15.828

5.  Recent progress and open challenges in modeling p53 dynamics in single cells.

Authors:  Eric Batchelor; Alexander Loewer
Journal:  Curr Opin Syst Biol       Date:  2017-03-25

6.  IPF lung fibroblasts have a senescent phenotype.

Authors:  Diana Álvarez; Nayra Cárdenes; Jacobo Sellarés; Marta Bueno; Catherine Corey; Vidya Sagar Hanumanthu; Yating Peng; Hannah D'Cunha; John Sembrat; Mehdi Nouraie; Swaroop Shanker; Chandler Caufield; Sruti Shiva; Mary Armanios; Ana L Mora; Mauricio Rojas
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-08-31       Impact factor: 5.464

7.  TRIM25 enhances cell growth and cell survival by modulating p53 signals via interaction with G3BP2 in prostate cancer.

Authors:  Ken-Ichi Takayama; Takashi Suzuki; Tomoaki Tanaka; Tetsuya Fujimura; Satoru Takahashi; Tomohiko Urano; Kazuhiro Ikeda; Satoshi Inoue
Journal:  Oncogene       Date:  2018-01-30       Impact factor: 9.867

8.  The Human Papillomavirus E6 Oncoprotein Targets USP15 and TRIM25 To Suppress RIG-I-Mediated Innate Immune Signaling.

Authors:  Cindy Chiang; Eva-Katharina Pauli; Jennifer Biryukov; Katharina F Feister; Melissa Meng; Elizabeth A White; Karl Münger; Peter M Howley; Craig Meyers; Michaela U Gack
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

9.  A Single Let-7 MicroRNA Bypasses LIN28-Mediated Repression.

Authors:  Robinson Triboulet; Mehdi Pirouz; Richard I Gregory
Journal:  Cell Rep       Date:  2015-10-01       Impact factor: 9.423

10.  TRIM25 activates AKT/mTOR by inhibiting PTEN via K63-linked polyubiquitination in non-small cell lung cancer.

Authors:  Yuan-Ming He; Xiu-Min Zhou; Shuo-Yi Jiang; Zu-Bin Zhang; Bi-Yin Cao; Jin-Bao Liu; Yuan-Ying Zeng; Jun Zhao; Xin-Liang Mao
Journal:  Acta Pharmacol Sin       Date:  2021-04-30       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.